Revised Schedule M for MSMEs: What Inspectors Look For in Batch Records

If you run a small or mid-size pharma plant in India, Revised Schedule M is probably already part of your weekly conversations. This article sets out the timeline, what it means for your batch records, and where an electronic batch record (eBMR) can help. It also covers the usual worries about cost, time and validation.

Where the timeline stands

• Revised Schedule M was notified in December 2023.
• Large firms (turnover above ₹250 crore) had to comply by 28 June 2024.
• MSMEs (₹250 crore or less) that applied with an upgrade plan had until 31 December 2025.
• For those MSMEs, the revised rules apply from 1 January 2026.
• In November 2025, the DCGI directed state regulators to inspect units and report monthly to CDSCO.

So inspections are expected, and the point is to be ready. Plants that prepare calmly and document well usually have a good conversation with the inspector.

What changed that touches batch records

Revised Schedule M adds three things that matter here:

1. A Pharmaceutical Quality System. Quality is managed as a system, not only as a final check.
2. A section on computerised systems. Systems you use must be validated.
3. Stricter batch processing and packaging records.

One point needs to be stated clearly: Revised Schedule M does not legally require electronic batch records. A well-run paper system can meet the requirement. What an eBMR does is make complete, attributable, reviewable records much easier to produce and to show to an inspector.

What inspectors look for in a batch record

We can't speak for any individual inspector, but the practical questions are easy to guess. When someone picks up a batch record, they want to know:

• Is it complete? Every step, check, limit and reconciliation has a value or a stated reason why not.
• Is it attributable? You can see who recorded each entry, who checked it, and when.
• Is it the right version? The batch was made on the approved master record revision, and you can show which one.
• Are corrections explained? Any change shows the original value, the new value and the reason.
• Was it reviewed before release? There is evidence of QA review and a named person who released the batch.
• Can you produce it quickly? A complete copy is available without a hunt through files.

Paper records can answer all of these, but it takes discipline, and gaps are easy to miss: a blank field, an unsigned check, an undated entry, or an old revision on the floor.

How eBMR helps with each question

Atto Pharma eBMR turns your own approved Word or PDF batch manufacturing and packing records into electronic screens. It records the batch on them: dispensing, lot processing, in-process checks, packing, reconciliation, review and release.

• Complete and reviewable. The batch is created and issued by the QA Head. People record on the screens of the operations they are cleared for, checkers verify, QA reviews each section, and the QA Head releases the batch. You can produce the electronic batch record as a PDF at any time, showing every value, limit, signer, time, exception, correction with its reason, review and release.
• Attributable. Each entry and signature carries the person and the time.
• Right version. Each revision of the source document and its screens is kept and never changed. A new revision needs a reason, for example the change-control number, and a batch stays on the revision it was made with.
• Protected. Records can't be deleted. Every saved version is kept in an append-only history, chained by SHA-256, so a change made outside the application is detected.

For equipment, area and instrument records, Atto eLogbooks does the same for logbooks, with export to Excel and PDF that includes corrections and cancelled entries.

Compliance still depends on your procedures and your validation. The software supports your controls. It does not make a site compliant by itself.

The usual hesitations, answered

"We can't afford it." Prices are published in rupees. In the Admin console (Billing, then Sales proposals) you enter the number of eBMR users and eLogbooks-only users, and the price shows as you type, in rupees with GST for a company in India. You can then make a proposal that is valid for 30 days and print it or save it as a PDF. No call is needed to find out what it would cost.

"We don't have time to retype all our records." You don't retype. Atto Pharma's converter turns your existing approved Word document, or a PDF saved from Word (not a scan), into screens. You then review the result: product details, points to check, and who may record each section. You can load up to 20 BMRs at once, and each becomes a draft for you to review before it becomes a product.

"Validation will be a mountain." It is still your responsibility, but you aren't starting from nothing. Each product is converted and checked in development, qualified (OQ) in QA, and then performance-qualified (PQ) and used in production. Atto Pharma provides an OQ and PQ module for each product version, an installation check (IQ), and a release record with test results for each release. Moving from one environment to the next needs the receiving QA Head's acceptance with a password. Your validation team still plans and signs off the work, but the structure and evidence are there.

Try it before you decide: the 14-day pilot

A company registers on the development site and, once Atto Pharma confirms it, gets a 14-day pilot. Some details worth knowing:

• Up to 10 pilot evaluators per company (a QA Head or Manufacturing Head) can record, check and release every step alone, so you can try the whole flow without gathering a full shift.
• Every batch and every printout made during the pilot is marked PILOT – not for GMP use, so nothing can be mistaken for a real record.
• Atto Pharma asks for your decision once, at the end, and sends no sales messages because of your answer.
• If you decide not to continue, the development site closes to your company.

A practical way to use the 14 days: take one batch record you know well, convert it, and run a batch through. Then ask your QA Head to look at the PDF and ask the same questions an inspector would.

Practical takeaways

• Know your unit's date and position under Revised Schedule M.
• Review a few recent batch records for blanks, unexplained corrections and version control. This works with paper or electronic records.
• Remember that computerised systems you use must be validated, so plan for it early.
• If you are considering an eBMR, test it with your own record, not a demo.

Atto Pharma eBMR and Atto eLogbooks can be tried in the free 14-day pilot. If it isn't right for your plant, you will know within two weeks.

This article is not legal advice. Check the official Schedule M notification and your State Drugs Controller for your unit's position.

---

Originally published on siddhi.today.